Étude de cas
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings
This executive summary details the key findings from the 5-dose MCV research in Zambia: improved coverage, reduced wastage, no cold chain constraints, and healthcare workers were more willing to open a 5-dose vial.
Auteurs
Langues
- Anglais
Année de publication
2019
Éditeur
Dose Per Container Partnership
Type
Étude de cas
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Rougeole
Pays
- Zambie
Organisations
- La Foundation Bill et Melinda Gates
Mots-clés
- Coverage monitoring
- Delivery device
- Planning, budgeting and financing
- Refrigerator / freezer
- Wastage
Régions de l'OMS
- Région africaine
Références sur le sujet
DPCP-CASE-STUDIES
PORTFOLIO-LESSONS
Titre | Auteur | Année | Type | Langue |
---|---|---|---|---|
A Switch for Sustainability in Ghana's Rotavirus Vaccine Program | Professor George Armah | 2020 | Case study | Anglais |
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings | Dose Per Container Partnership | 2019 | Case study | Anglais |
The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia | Ali Karim, Barbara Knittel, Frances Mwansa, Guissimon Phiri, Kirstin Krudwig, Natasha Kanagat, Robert Steinglass, Wendy Prosser | 2020 | Journal article | Anglais |